| Crisis And Counseling Centers, Inc. | |
|
10 Caldwell Rd Augusta ME 04330 | |
| (207) 626-3448 | |
| (207) 626-3453 |
| Full Name | Crisis And Counseling Centers, Inc. |
|---|---|
| Speciality | Counselor |
| Location | 10 Caldwell Rd, Augusta, Maine |
| Authorized Official Name and Position | Michael Mitchell (EXECUTIVE DIRECTOR) |
| Authorized Official Contact | 2076263448 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Crisis And Counseling Centers, Inc. 10 Caldwell Rd Augusta ME 04330-5735 Ph: (207) 626-3448 | Crisis And Counseling Centers, Inc. 10 Caldwell Rd Augusta ME 04330 Ph: (207) 626-3448 |
| NPI Number | 1558382747 |
|---|---|
| Provider Enumeration Date | 07/22/2006 |
| Last Update Date | 04/01/2021 |
| Certification Date | 04/01/2021 |
| Medicare PECOS PAC ID | 2668407727 |
|---|---|
| Medicare Enrollment ID | O20050928000547 |
News Archive
Anacor Pharmaceuticals announced today that the first patient has been enrolled in the Phase 3 trial of AN2728, a novel boron-based phosphodiesterase-4 (PDE-4) inhibitor, for the topical treatment of mild-to-moderate atopic dermatitis. Atopic dermatitis is a chronic rash characterized by inflammation and itch and affects approximately 10% - 20% of infants and young children.
A new campaign called FurtherMore has been launched by Eisai with advice from pan-European and national patient associations.
According to the Surgeon General, only one-third of Americans with a mental health problem seek treatment; the percentage of African Americans getting help is only half that of non-Hispanic whites.
Hundreds of thousands of Medicare beneficiaries who have been denied coverage for nursing home stays because their time in the hospital was changed from "inpatient" to "observation care" can now appeal to Medicare for reimbursement, a federal judge in Hartford, Connecticut, ruled last week.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558382747 | NPI | - | NPPES |
| 1558382747 | Medicaid | ME |
| Provider Name | Jean N Hair |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1861410227 PECOS PAC ID: 7416989363 Enrollment ID: I20050831000635 |
News Archive
Anacor Pharmaceuticals announced today that the first patient has been enrolled in the Phase 3 trial of AN2728, a novel boron-based phosphodiesterase-4 (PDE-4) inhibitor, for the topical treatment of mild-to-moderate atopic dermatitis. Atopic dermatitis is a chronic rash characterized by inflammation and itch and affects approximately 10% - 20% of infants and young children.
A new campaign called FurtherMore has been launched by Eisai with advice from pan-European and national patient associations.
According to the Surgeon General, only one-third of Americans with a mental health problem seek treatment; the percentage of African Americans getting help is only half that of non-Hispanic whites.
Hundreds of thousands of Medicare beneficiaries who have been denied coverage for nursing home stays because their time in the hospital was changed from "inpatient" to "observation care" can now appeal to Medicare for reimbursement, a federal judge in Hartford, Connecticut, ruled last week.
› Verified 8 days ago
| Provider Name | Sandra J Aube-langella |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1306883129 PECOS PAC ID: 3678675816 Enrollment ID: I20070219000642 |
News Archive
Anacor Pharmaceuticals announced today that the first patient has been enrolled in the Phase 3 trial of AN2728, a novel boron-based phosphodiesterase-4 (PDE-4) inhibitor, for the topical treatment of mild-to-moderate atopic dermatitis. Atopic dermatitis is a chronic rash characterized by inflammation and itch and affects approximately 10% - 20% of infants and young children.
A new campaign called FurtherMore has been launched by Eisai with advice from pan-European and national patient associations.
According to the Surgeon General, only one-third of Americans with a mental health problem seek treatment; the percentage of African Americans getting help is only half that of non-Hispanic whites.
Hundreds of thousands of Medicare beneficiaries who have been denied coverage for nursing home stays because their time in the hospital was changed from "inpatient" to "observation care" can now appeal to Medicare for reimbursement, a federal judge in Hartford, Connecticut, ruled last week.
› Verified 8 days ago
| Provider Name | Jennifer Olin |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1184074619 PECOS PAC ID: 4284968785 Enrollment ID: I20190702002463 |
News Archive
Anacor Pharmaceuticals announced today that the first patient has been enrolled in the Phase 3 trial of AN2728, a novel boron-based phosphodiesterase-4 (PDE-4) inhibitor, for the topical treatment of mild-to-moderate atopic dermatitis. Atopic dermatitis is a chronic rash characterized by inflammation and itch and affects approximately 10% - 20% of infants and young children.
A new campaign called FurtherMore has been launched by Eisai with advice from pan-European and national patient associations.
According to the Surgeon General, only one-third of Americans with a mental health problem seek treatment; the percentage of African Americans getting help is only half that of non-Hispanic whites.
Hundreds of thousands of Medicare beneficiaries who have been denied coverage for nursing home stays because their time in the hospital was changed from "inpatient" to "observation care" can now appeal to Medicare for reimbursement, a federal judge in Hartford, Connecticut, ruled last week.
› Verified 8 days ago
| Provider Name | Heather Shorey |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1053808725 PECOS PAC ID: 2668882192 Enrollment ID: I20201111002461 |
News Archive
Anacor Pharmaceuticals announced today that the first patient has been enrolled in the Phase 3 trial of AN2728, a novel boron-based phosphodiesterase-4 (PDE-4) inhibitor, for the topical treatment of mild-to-moderate atopic dermatitis. Atopic dermatitis is a chronic rash characterized by inflammation and itch and affects approximately 10% - 20% of infants and young children.
A new campaign called FurtherMore has been launched by Eisai with advice from pan-European and national patient associations.
According to the Surgeon General, only one-third of Americans with a mental health problem seek treatment; the percentage of African Americans getting help is only half that of non-Hispanic whites.
Hundreds of thousands of Medicare beneficiaries who have been denied coverage for nursing home stays because their time in the hospital was changed from "inpatient" to "observation care" can now appeal to Medicare for reimbursement, a federal judge in Hartford, Connecticut, ruled last week.
› Verified 8 days ago
| Provider Name | Lorie Welsh |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1497997605 PECOS PAC ID: 2365893526 Enrollment ID: I20240111004116 |
News Archive
Anacor Pharmaceuticals announced today that the first patient has been enrolled in the Phase 3 trial of AN2728, a novel boron-based phosphodiesterase-4 (PDE-4) inhibitor, for the topical treatment of mild-to-moderate atopic dermatitis. Atopic dermatitis is a chronic rash characterized by inflammation and itch and affects approximately 10% - 20% of infants and young children.
A new campaign called FurtherMore has been launched by Eisai with advice from pan-European and national patient associations.
According to the Surgeon General, only one-third of Americans with a mental health problem seek treatment; the percentage of African Americans getting help is only half that of non-Hispanic whites.
Hundreds of thousands of Medicare beneficiaries who have been denied coverage for nursing home stays because their time in the hospital was changed from "inpatient" to "observation care" can now appeal to Medicare for reimbursement, a federal judge in Hartford, Connecticut, ruled last week.
› Verified 8 days ago
| Provider Name | Diana L James |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1174703201 PECOS PAC ID: 9234582925 Enrollment ID: I20240130000664 |
News Archive
Anacor Pharmaceuticals announced today that the first patient has been enrolled in the Phase 3 trial of AN2728, a novel boron-based phosphodiesterase-4 (PDE-4) inhibitor, for the topical treatment of mild-to-moderate atopic dermatitis. Atopic dermatitis is a chronic rash characterized by inflammation and itch and affects approximately 10% - 20% of infants and young children.
A new campaign called FurtherMore has been launched by Eisai with advice from pan-European and national patient associations.
According to the Surgeon General, only one-third of Americans with a mental health problem seek treatment; the percentage of African Americans getting help is only half that of non-Hispanic whites.
Hundreds of thousands of Medicare beneficiaries who have been denied coverage for nursing home stays because their time in the hospital was changed from "inpatient" to "observation care" can now appeal to Medicare for reimbursement, a federal judge in Hartford, Connecticut, ruled last week.
› Verified 8 days ago
News Archive
Anacor Pharmaceuticals announced today that the first patient has been enrolled in the Phase 3 trial of AN2728, a novel boron-based phosphodiesterase-4 (PDE-4) inhibitor, for the topical treatment of mild-to-moderate atopic dermatitis. Atopic dermatitis is a chronic rash characterized by inflammation and itch and affects approximately 10% - 20% of infants and young children.
A new campaign called FurtherMore has been launched by Eisai with advice from pan-European and national patient associations.
According to the Surgeon General, only one-third of Americans with a mental health problem seek treatment; the percentage of African Americans getting help is only half that of non-Hispanic whites.
Hundreds of thousands of Medicare beneficiaries who have been denied coverage for nursing home stays because their time in the hospital was changed from "inpatient" to "observation care" can now appeal to Medicare for reimbursement, a federal judge in Hartford, Connecticut, ruled last week.
› Verified 8 days ago
Esm, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 776 Riverside Dr, Augusta, ME 04330 Phone: 207-622-5946 Fax: 207-622-4667 | |
Augusta Neurology Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 55 Middle Street, Suite 1, Augusta, ME 04330 Phone: 207-626-5445 Fax: 207-626-5446 | |
Green Zone Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6 Baldwin St, Augusta, ME 04330 Phone: 207-592-6911 | |
Maine Behavioral Health Organization Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 49 Oak St, Augusta, ME 04330 Phone: 207-458-4642 | |
Suzanne White, Lcsw Corp Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 49 Oak St, Augusta, ME 04330 Phone: 207-649-4047 Fax: 207-622-6290 | |
Graham Behavioral Services, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 76 Eastern Ave, Augusta, ME 04330 Phone: 207-626-0003 Fax: 207-626-0004 | |
Thepleasantoak, Inc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 49 Oak St, Augusta, ME 04330 Phone: 207-441-6624 Fax: 207-622-6290 |